Search Results - "Avni, Irit"
-
1
Editorial: ustekinumab during pregnancy—reassuring but still not enough. Authors' reply
Published in Alimentary pharmacology & therapeutics (01-01-2023)“…LINKED CONTENT This article is linked to Avni‐Biron et al papers. To view these articles, visit https://doi.org/10.1111/apt.17224 and…”
Get full text
Journal Article -
2
Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study
Published in Alimentary pharmacology & therapeutics (01-11-2022)“…Summary Background Women with inflammatory bowel diseases (IBD) often receive biologics to maintain remission during pregnancy. Aims To assess maternal and…”
Get full text
Journal Article -
3
Capsule Endoscopy Crohn’s Disease Activity Index (CECDAIic or Niv Score) for the Small Bowel and Colon
Published in Journal of clinical gastroenterology (01-01-2018)“…BACKGROUND AND THE STUDY AIM:Crohn’s disease (CD) is a chronic inflammatory disorder defined as a transmural inflammation of the bowel wall, affecting the…”
Get full text
Journal Article -
4
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center
Published in Journal of clinical medicine (18-06-2023)“…Inflammatory bowel disease (IBD) can have an impact on pregnancy outcomes due to the effect of the disease activity and medication use. This study aimed to…”
Get full text
Journal Article -
5
Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic
Published in Therapeutic advances in gastroenterology (2021)“…Background and Aims: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading…”
Get full text
Journal Article -
6
Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study
Published in The American journal of gastroenterology (01-07-2019)“…Despite encouraging data gathered in inflammatory bowel diseases (IBD) patients, Vedolizumabs' (VDZ) safety profile in pregnancy is not established. Data of…”
Get full text
Journal Article -
7
Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases
Published in Therapeutic advances in gastroenterology (01-01-2022)“…Background: Evidence regarding the risk of immunogenicity in patients with inflammatory bowel disease (IBD) who switched anti-tumor necrosis factor alpha…”
Get full text
Journal Article -
8
SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy
Published in Vaccines (Basel) (29-10-2022)“…Introduction: Regulatory agencies supported vaccination of pregnant women with SARS-CoV-2 mRNA vaccines, including patients with IBD. No data exist regarding…”
Get full text
Journal Article -
9
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience
Published in Inflammatory bowel diseases (01-03-2017)“…Vedolizumab (VDZ) is an anti-integrin monoclonal antibody effective in ulcerative colitis (UC) and Crohn's disease (CD). The aim of this study was to examine…”
Get full text
Journal Article -
10
Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study
Published in Annals of medicine (Helsinki) (01-12-2024)“…Real-world data on tofacitinib's effectiveness is limited and mainly retrospective or registry-based. We elected to conduct a pragmatic prospective study to…”
Get full text
Journal Article -
11
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD
Published in Journal of Crohn's and colitis (23-04-2024)“…Abstract Background Recruitment for randomized controlled trials [RCTs] in inflammatory bowel diseases [IBD] has substantially dropped over time. This study…”
Get full text
Journal Article Web Resource -
12
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]
Published in Journal of Crohn's and colitis (08-09-2022)“…Abstract Aims i] To evaluate the evolution of pregnancies and offspring after inflammatory bowel disease [IBD] surgery during pregnancy; and ii] to describe…”
Get full text
Journal Article -
13
Multidisciplinary Perinatal Care in IBD
Published in Journal of Crohn's and colitis (03-05-2023)“…Abstract Background and Aims Patients with inflammatory bowel disease [IBD] are often affected during their reproductive years and may have many perinatal…”
Get full text
Journal Article -
14
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease—The Israeli real world experience
Published in Digestive and liver disease (01-01-2019)“…Several real-world experience (RWE) studies with vedolizumab (VDZ) for induction of remission in inflammatory bowel diseases (IBD) have been published;…”
Get full text
Journal Article -
15
The Role of Small-Bowel Capsule Endoscopy in the Diagnostic Algorithm of Complicated Perianal Disease
Published in Diagnostics (Basel) (09-08-2024)“…Complicated perianal disease (cPD) may be the sole presentation of Crohn's disease (CD). The role of small-bowel capsule endoscopy (SBCE) in the diagnostic…”
Get full text
Journal Article -
16
Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial
Published in The American journal of gastroenterology (01-02-2023)“…Whether fecal calprotectin (FC) and quality of life (QoL) questionnaires reflect change in disease activity in patients with a J-pouch is unknown. Patients…”
Get full text
Journal Article -
17
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
Published in Vaccines (Basel) (26-07-2022)“…Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the…”
Get full text
Journal Article -
18
Immune function in newborns with in-utero exposure to anti-TNFα therapy
Published in Frontiers in pediatrics (31-08-2022)“…Background and aimAnti-TNFα is measurable in infants exposed in utero up to 12 months of age. Data about the exposure effect on the infant's adaptive immunity…”
Get full text
Journal Article -
19
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
Published in Vaccines (Basel) (01-07-2023)“…Vaccines are pivotal for control of the coronavirus disease (COVID-19) pandemic. Patients with inflammatory bowel diseases (IBDs) treated with antitumor…”
Get full text
Journal Article -
20
COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
Published in Vaccines (Basel) (28-02-2022)“…Crohn's disease (CD) and ulcerative colitis (UC) are chronic, immune-mediated inflammatory bowel diseases (IBD) affecting millions of people worldwide. IBD…”
Get full text
Journal Article